Amfenac

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 28O5C1J38A. European Medicines Agency schedules Amfenac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05415MIG. Amfenac generally arises in the molecular formula C15H13NO3. The term AMFENAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, no 10 1978, list 18.) AMFENAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amfenac under HS 29225000 and SITC 51467. As of Q4 2014, AMFENAC remains the US FDA Preferred Term for this commodity. Amfenac bears US NLM identifiers UMLS ID C0051572 and NCI Concept Code C73071. SMILES: O=C(C1C(N)C(CC(=O)O)CCC1)C1CCCCC1.